Brief: Prelude Therapeutics Q2 Loss Per Share $0.58

Prelude Therapeutics Incorporated

12/08/2021 12:40

Aug 12 (Reuters) - Prelude Therapeutics Inc  PRLD.O :
    * Q2 LOSS PER SHARE $0.58
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES
DATA
    * CASH AND CASH EQUIVALENTS AS OF JUNE 30, 2021 WERE $343.1
MILLION
    * PRELUDE THERAPEUTICS - BELIEVES CURRENT CASH, CASH
EQUIVALENTS
WILL BE SUFFICIENT TO FUND OPERATING EXPENSES & CAPEX
REQUIREMENTS INTO MID-2023

Source text for Eikon:  ID:nGNX37YlkB 
Further company coverage:  PRLD.O 

 ((Reuters.Briefs@thomsonreuters.com;))